These findings implicate that the oncogenic NPM-ALK fusion gene not only could directly activate STAT3 oncogenic signaling, but also potentially grant these fusion-bearing cancer cells additional immune evasion ability by upregulating multiple immunosuppressive mechanisms. Here, NPM1 is linked to cancer.